| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |